Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genevieve Boland

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Cancer Cell|November 4, 2022
Could SIRPA expression predict response to anti-PD-1 immunotherapy?Kristen Jogerst, Genevieve Boland
Annals of Surgical Oncology|May 24, 2023
ASO Author Reflections: The Evolution of Surgery for Patients with Stage IV MelanomaThinzar Lwin, George Molina, Genevieve Boland
The Journal of Biological Chemistry|June 22, 2002
Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cellsLeslie Fischer, Genevieve Boland, Rocky S Tuan
Arthritis Research & Therapy|April 30, 2003
Adult mesenchymal stem cells and cell-based tissue engineeringRocky S Tuan, Genevieve Boland, Richard Tuli
Journal of Cellular Biochemistry|February 9, 2002
Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesisLeslie Fischer, Genevieve Boland, Rocky S Tuan
Surgical Oncology Clinics of North America|February 24, 2024
Precision Oncology in Melanoma and Skin Cancer SurgeryShoshana Levi, Hannah Bank, John Mullinax, et al.
Annals of Surgical Oncology|April 30, 2023
Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy EraThinzar M Lwin, Zoey Kaelberer, Mengyuan Ruan, et al.
Surgical Oncology Clinics of North America|May 14, 2019
Oncolytic ImmunotherapyMorgan L Hennessy, Praveen K Bommareddy, Genevieve Boland, et al.
Cancers|June 22, 2023
Machine Learning Improves the Prediction of Responses to Immune Checkpoint Inhibitors in Metastatic MelanomaAzadeh Tabari, Meredith Cox, Brian D'Amore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET ImagingBenjamin M Larimer, Emily Bloch, Sarah Nesti, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Cancer Cell|November 4, 2022
Could SIRPA expression predict response to anti-PD-1 immunotherapy?Kristen Jogerst, Genevieve Boland
Annals of Surgical Oncology|May 24, 2023
ASO Author Reflections: The Evolution of Surgery for Patients with Stage IV MelanomaThinzar Lwin, George Molina, Genevieve Boland
The Journal of Biological Chemistry|June 22, 2002
Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cellsLeslie Fischer, Genevieve Boland, Rocky S Tuan
Arthritis Research & Therapy|April 30, 2003
Adult mesenchymal stem cells and cell-based tissue engineeringRocky S Tuan, Genevieve Boland, Richard Tuli
Journal of Cellular Biochemistry|February 9, 2002
Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesisLeslie Fischer, Genevieve Boland, Rocky S Tuan
Surgical Oncology Clinics of North America|February 24, 2024
Precision Oncology in Melanoma and Skin Cancer SurgeryShoshana Levi, Hannah Bank, John Mullinax, et al.
Annals of Surgical Oncology|April 30, 2023
Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy EraThinzar M Lwin, Zoey Kaelberer, Mengyuan Ruan, et al.
Surgical Oncology Clinics of North America|May 14, 2019
Oncolytic ImmunotherapyMorgan L Hennessy, Praveen K Bommareddy, Genevieve Boland, et al.
Cancers|June 22, 2023
Machine Learning Improves the Prediction of Responses to Immune Checkpoint Inhibitors in Metastatic MelanomaAzadeh Tabari, Meredith Cox, Brian D'Amore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET ImagingBenjamin M Larimer, Emily Bloch, Sarah Nesti, et al.
Pageof 5